LCDActive
MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
L37003
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: August 24, 2023
Updated: December 31, 2025
Policy Summary
HLA-DQB1*06:02 typing (CPT 81383) is considered experimental/investigational and is not covered for diagnosis or management of narcolepsy in any population. The test lacks diagnostic utility because it cannot confirm or exclude narcolepsy or quantify individual risk, and a substantial proportion of unaffected people carry the allele while some affected individuals lack it.
Coverage Criteria Preview
Key requirements from the full policy
"HLA-DQB1*06:02 typing (CPT 81383) for the diagnosis or management of narcolepsy is considered experimental, investigational, or unproven for all populations and is not covered."
Sign up to see full coverage criteria, indications, and limitations.